Impact of COVID-19 on the Destiny of Bariatric Patients

Obese patients reported worse outcomes of COVID-19 related to prothrombotic and low-grade inflammation status. During the SARS-CoV-2 outbreak, all non-elective surgeries were postponed, including bariatric surgery (BS). This umbrella review wants to underline obesity as a condition provoking low-gra...

Full description

Saved in:
Bibliographic Details
Published in:Nutrients 2022-12, Vol.15 (1), p.163
Main Authors: Gualtieri, Paola, Marchetti, Marco, Renzo, Laura Di, De Santis, Gemma Lou, Palma, Roselisa, Colica, Carmela, Frank, Giulia, De Lorenzo, Antonino, Di Lorenzo, Nicola
Format: Article
Language:English
Subjects:
Bariatric Surgery
Body mass index
Body weight loss
Care and treatment
Comorbidity
Complications and side effects
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - etiology
Economic impact
Health policy
Humans
Impact analysis
Inflammation
Inflammation - etiology
Literature reviews
metabolic surgery
Mortality
Obesity
Obesity - complications
Obesity - epidemiology
Obesity, Morbid - complications
Obesity, Morbid - surgery
Pandemics
Patients
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Surgery
Weight loss
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Obese patients reported worse outcomes of COVID-19 related to prothrombotic and low-grade inflammation status. During the SARS-CoV-2 outbreak, all non-elective surgeries were postponed, including bariatric surgery (BS). This umbrella review wants to underline obesity as a condition provoking low-grade chronic inflammation, and increasing severe COVID-19 risk; to relaunch the prioritization of BS. The literature search was conducted in March 2022 via Pubmed (MEDLINE) and focused on reviews, systematic reviews, and meta-analyses published in peer-reviewed journals. Terms "bariatric surgery" OR "obesity surgery" OR "metabolic surgery" were analyzed with "COVID-19" OR "SARS-CoV-2" using the AND modifier. Only 13 studies of the 406 screened met the objective. The procrastination of BS over the past two years determined a delay in obesity treatment and severe consequences. The COVID-19 pandemic has had a huge impact on economic costs. Although BS has high costs, a lifetime cost advantage over conventional weight loss methods was demonstrated. As the pandemic continues, health policies must recognize obesity as a disease-predisposing factor for SARS-CoV-2 infection, considering COVID-19 as a new comorbidity mitigable by BS. Care pathways for obese patients in COVID/post-COVID era should be revitalized and the concept of elective surgery attributed to BS should be reformulated.
ISSN:2072-6643
2072-6643
DOI:10.3390/nu15010163